ctHPVDNA in HPV Positive Squamous Cell Carcinoma of the Oropharynx

This study is a prospective phase II trial, designed to assess the efficacy and feasibility of adjuvant treatment deintensification guided by ctHPVDNA levels for patients with HPV+OPSCC who undergo transoral surgery and neck dissection.

Trial Details

NCT ID
NCT06915038
Phase
NA
Sponsor
Indiana University
Status
RECRUITING
Cancer Type
HPV Positive Head and Neck Cancer
Interventions
  • NavDx
  • Adjuvant Radiation 30 Gray
  • Adjuvant Radiation 40 Gray
Locations (sample)
  • Carmel, Indiana, United States|39.97837,-86.11804
  • Indianapolis, Indiana, United States|39.76838,-86.15804

Key Eligibility Criteria

  • Pre-Surgery
  • Subjects ≥ 18 years old at the time of informed consent.
  • Ability to provide written informed consent and HIPAA authorization.
  • Eastern Cooperative Oncology Group (ECOG) performance status 0-2.

For full eligibility, visit ClinicalTrials.gov.

Check If You May Be Eligible

Trialify translates complex eligibility criteria into plain yes-or-no questions to help you understand if this trial might be right for you.

Find HPV Positive Head and Neck Cancer Trials on Trialify →